Needham & Company Reiterates a 'Buy' on Hologic (HOLX); Waiting 'Til November for GPRO Insight
Tweet Send to a Friend
Needham & Company reiterates a 'Buy' on Hologic (NASDAQ: HOLX) price target of $22.00.
Analyst, Dalton Chandler, said, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Dalton Chandler, said, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
